1. 2023
  2. Evaluation of Systemic Treatments of Small Intestinal Adenocarcinomas: A Systematic Review and Meta-analysis

    de Back, T., Nijskens, I., Schafrat, P., Chalabi, M., Kazemier, G., Vermeulen, L. & Sommeijer, D., 24 Feb 2023, In: JAMA network open. 6, 2, p. E230631

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2022
  4. Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes

    Adam, R. S., Poel, D., Ferreira Moreno, L., Spronck, J. M. A., de Back, T. R., Torang, A., Gomez Barila, P. M., ten Hoorn, S., Markowetz, F., Wang, X., Verheul, H. M. W., Buffart, T. E. & Vermeulen, L., Jul 2022, In: Molecular oncology. 16, 14, p. 2693-2709 17 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis

    ten Hoorn, S., de Back, T. R., Sommeijer, D. W. & Vermeulen, L., 1 Apr 2022, In: Journal of the National Cancer Institute. 114, 4, p. 503-516 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  6. Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer

    ten Hoorn, S., Mol, L., Sommeijer, D. W., Nijman, L., van den Bosch, T., de Back, T. R., Ylstra, B., van Dijk, E., van Noesel, C. J. M., Reinten, R. J., Nagtegaal, I. D., Koopman, M., Punt, C. J. A. & Vermeulen, L., 2022, (E-pub ahead of print) In: Clinical colorectal cancer.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2021
  8. Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone

    ten Hoorn, S., Sommeijer, D. W., Elliott, F., Fisher, D., de Back, T. R., Trinh, A., Koens, L., Maughan, T., Seligmann, J., Seymour, M. T., Quirke, P., Adams, R., Richman, S. D., Punt, C. J. A. & Vermeulen, L., 12 Oct 2021, In: British journal of cancer. 125, 8, p. 1080-1088 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors

    Gaartman, A. E., Sayedi, A. K., Gerritsma, J. J., de Back, T. R., van Tuijn, C. F., Tang, M. W., Heijboer, H., de Heer, K., Biemond, B. J. & Nur, E., 1 Sept 2021, In: British journal of haematology. 194, 5, p. 899-907 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. 2019
  11. Auto-immuuncytopenieën bij patiënten met chronische lymfatische leukemie: een beknopt overzicht met aanbevelingen voor de praktijk

    de Back, T., Kater, A. & Tonino, S. H., 2019, In: Nederlands tijdschrift voor hematologie. 11, p. 321-328

    Research output: Contribution to journalArticleProfessional

ID: 7052704